tiprankstipranks
Sonova Holding AG Unsponsored ADR (SONVY)
OTHER OTC:SONVY
Want to see SONVY full AI Analyst Report?

Sonova Holding AG (SONVY) Price & Analysis

32 Followers

SONVY Stock Chart & Stats

$51.72
$1.70(3.30%)
At close: 4:00 PM EDT
$51.72
$1.70(3.30%)

Bulls Say, Bears Say

Bulls Say
High Profitability & MarginsSonova's very high gross margins and solid EBITDA margins reflect durable pricing power, a premium product mix and scale across manufacturing and distribution. Sustained margin levels support continued R&D investment, multi-channel expansion and operating leverage over the medium term.
Strong Cash Generation & Capital EfficiencyConsistent free cash flow conversion and a high ROCE signal capital-efficient operations. Reliable cash generation supports a rising dividend, disciplined bolt-on M&A and funding for product launches without heavy new borrowing, improving resilience over the next several quarters.
Product Leadership & Share GainsRecent product launches drove notable wholesale momentum and the largest year-on-year market share gain since the Marvel platform. Device innovation and recurring revenue from newer products strengthen competitive differentiation and support sustainable market-share and recurring sales growth.
Bears Say
Cochlear Implants WeaknessThe CI business is materially underperforming with low margins and volume sensitivity. Prolonged CI weakness would weigh on group growth, dilute overall profitability and require management to allocate resources or accept lower consolidated returns until volumes and pricing recover.
China Policy & Competitive PressureStructural procurement shifts and new competitor products in China have reduced pricing power and market access for CI systems. If these dynamics persist, China could remain a constrained market for implants, limiting recovery timing and capping volume and margin potential in a key region.
Leverage Not Meaningfully DeleveredDebt-to-equity in the mid-range and limited deleveraging reduce financial flexibility versus best-in-class peers. That constrains capacity for large inorganic deals, makes the company more sensitive to adverse shocks, and limits optionality for aggressive capital returns if conditions deteriorate.

Sonova Holding AG News

SONVY FAQ

What was Sonova Holding AG Unsponsored ADR’s price range in the past 12 months?
Sonova Holding AG Unsponsored ADR lowest stock price was $42.66 and its highest was $60.66 in the past 12 months.
    What is Sonova Holding AG Unsponsored ADR’s market cap?
    Sonova Holding AG Unsponsored ADR’s market cap is $17.07B.
      When is Sonova Holding AG Unsponsored ADR’s upcoming earnings report date?
      Sonova Holding AG Unsponsored ADR’s upcoming earnings report date is Nov 12, 2026 which is in 86 days.
        How were Sonova Holding AG Unsponsored ADR’s earnings last quarter?
        Sonova Holding AG Unsponsored ADR released its earnings results on May 18, 2026. The company reported $1.439 earnings per share for the quarter, beating the consensus estimate of $1.438 by $0.001.
          Is Sonova Holding AG Unsponsored ADR overvalued?
          According to Wall Street analysts Sonova Holding AG Unsponsored ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sonova Holding AG Unsponsored ADR pay dividends?
            Sonova Holding AG Unsponsored ADR pays a Annually dividend of $1.16 which represents an annual dividend yield of 1.96%. See more information on Sonova Holding AG Unsponsored ADR dividends here
              What is Sonova Holding AG Unsponsored ADR’s EPS estimate?
              Sonova Holding AG Unsponsored ADR’s EPS estimate is 1.11.
                How many shares outstanding does Sonova Holding AG Unsponsored ADR have?
                Sonova Holding AG Unsponsored ADR has 298,134,030 shares outstanding.
                  What happened to Sonova Holding AG Unsponsored ADR’s price movement after its last earnings report?
                  Sonova Holding AG Unsponsored ADR reported an EPS of $1.439 in its last earnings report, beating expectations of $1.438. Following the earnings report the stock price went up 7.936%.
                    Which hedge fund is a major shareholder of Sonova Holding AG Unsponsored ADR?
                    Currently, no hedge funds are holding shares in SONVY
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Sonova Holding AG Stock Smart Score

                      6
                      Neutral
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10

                      Technicals

                      SMA
                      Negative
                      20 days / 200 days
                      Momentum
                      -26.09%
                      12-Months-Change

                      Fundamentals

                      Return on Equity
                      1.96%
                      Trailing 12-Months
                      Asset Growth
                      4.61%
                      Trailing 12-Months

                      Company Description

                      Sonova Holding AG Unsponsored ADR

                      Sonova Holding AG is a prominent developer, manufacturer, and global distributor of hearing health solutions for all age groups. The company's operations are divided into two core areas: Hearing Instruments and Cochlear Implants. Its product range includes sophisticated wireless communication devices, innovative rechargeable hearing aids, and a comprehensive selection of consumer audio electronics such as wireless headsets, hearables designed for speech enhancement, high-fidelity headphones, microphones, and wireless transmission systems. Furthermore, Sonova offers extensive audiological care services. Key brands under its umbrella include Phonak, Unitron, and Hansaton for hearing instruments; Advanced Bionics for cochlear implants; and Sennheiser for consumer audio. Its audiological care services are delivered through a vast network of approximately 3,600 retail locations and clinics, known by various regional names including AudioNova, Audium, and Connect Hearing. Sonova distributes its products through independent partners and provides services via its direct network. The company maintains a significant international presence, operating in the United States, Europe, the Middle East, Africa, and the Asia Pacific region. Established in Stäfa, Switzerland, in 1947, the firm was formerly known as Phonak Holding AG before adopting its current name, Sonova Holding AG, in August 2007.

                      Sonova Holding AG (SONVY) Earnings & Revenues

                      SONVY Company Deck

                      SONVY Earnings Call

                      Q4 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Positive
                      The call highlights strong product-led sales momentum (notably in wholesale and select APAC markets), meaningful operating leverage, high cash conversion and disciplined capital allocation. Key short-term challenges are concentrated in the Cochlear Implants business (notably China) and several non‑core one-off charges plus FX headwinds. Management provided a confident but execution‑sensitive midterm roadmap (innovation, multi-channel expansion, operational savings) and reiterated growth and margin guidance for FY26/27.View all SONVY earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Abbott Laboratories
                      Medtronic
                      LivaNova
                      Inspire Medical Systems
                      Envoy Medical

                      Ownership Overview

                      <0.01%<0.01%99.99%
                      Insiders
                      <0.01% Other Institutional Investors
                      99.99% Public Companies and
                      Individual Investors
                      Popular Stocks